Thomas P. Mathers, Chief Executive Officer at CoLucid Pharmaceuticals, Inc. (CLCD), sold 6,000 shares at $23.30 ($140K) on 2016-09-14, disclosed to the SEC on 2016-09-16.
Open-market sale of $140k CLCD by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.30 | 5,700 | $133K | 94.9% |
| 2 | $23.78 | 300 | $7K | 5.1% |
| Total | $23.32 avg | 6,000 | $140K | 100% |
| Filing → |
| CLCD | SELL | 2016-11-07 | $43K | — | Filing → |
| CLCD | SELL | 2016-10-05 | $111K | — | Filing → |
| CLCD | SELL | 2016-09-07 | $201K | — | Filing → |